Ask AI

All Questions

161
0

How to Showcase Your Track Record with Confidential Deals and Influencer SPVs?

regarding this _'(Track Record) Examine your Track Record of Past Deals. First identify the top five Past Deals that you have either invested in or had a role in writing the name of the company and a few words describing the business. Next think back to exactly how you initially discovered each opportunity and write a sentence that describes how you sourced each Past Deal. Then quantify how each Past Deal will be attractive to Limited Partners by looking at how the company grew how the valuation increased or how much money was generated by the exit and write a sentence about how value was created at each Past Deal. Lastly reflect on how your actions increased the value created at each Past Deal and write a sentence on your Value Add for each business.'_ - if most of your deals have been through angellist syndicates which contain confidentiality rules that mean you can't name the businesses you've invested in through them plus one deal that you can name that was brought to you as part of an influencer SPV (e.g. given equity) how should you handle this?

0

Is Establishing a C-Corp Accelerator with $3M/yr Funding from a Japanese City a Viable Long-Term Ecosystem Strategy?

We are building an accelerator backed by a city in Japan. Because of their budgetary process they will be putting about $3M/yr in 3 consecutive years. We currently are planning to establish a c-corp for the accelerator and operate it for a few years before adding funds. So the accelerator c-corp works as a vehicle for investments. We are designing it in this way for the longer-term ecosystem creation perspective - i.e. getting longer and more active commitments from Japanese CVC's. After sitting on two AMAs I got a feeling this is not such a good idea. Would you give us your thoughts on this? (Note that as we need to present it for the city council's budgetary approval in a week or so we would like to see good bad ugly of this premature idea...)